Lung cancer surgery equipment market seen reaching $5.1 billion by 2030

The lung cancer surgery equipment market is projected to grow from $3.73 billion in 2025 to $5.1 billion by 2030, driven by rising lung cancer cases, robotic-assisted tools and more minimally invasive procedures. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - The market is expanding as lung cancer incidence rises and hospitals invest in more precise surgical tools. - Growth in minimally invasive and robotic-assisted surgery could change how lung cancer is diagnosed, treated and monitored. - The projected rise to $5.1 billion by 2030 signals steady demand for advanced thoracic surgery equipment across global health systems.

What happened: - The Business Research Company released its "Lung Cancer Surgery Equipment Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The report estimates the global lung cancer surgery equipment market will grow from $3.73 billion in 2025 to $3.98 billion in 2026. - The market is forecast to reach $5.1 billion by 2030, at a 6.4% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company published the release on Aug. 14, 2026, from London.

The details: - Lung cancer surgery equipment includes surgical instruments, imaging devices, biopsy tools, electrosurgical apparatus, access devices and patient monitoring systems. - These tools support tumor removal, reduce surgical complications and aid recovery through precise intervention and continuous monitoring. - Historical growth has been linked to limited access to advanced thoracic surgery tools, reliance on open surgery, higher lung cancer incidence, more hospitals and surgical clinics, and widespread use of standard biopsy and imaging methods. - Future growth is tied to robotic-assisted and minimally invasive instruments, AI-powered imaging and monitoring systems, higher research investment, wider use of enhanced recovery after surgery protocols and more specialized lung cancer treatment centers. - The report says key trends include stronger demand for minimally invasive lung surgeries, advanced diagnostic and imaging technology, device-integrated patient monitoring, postoperative rehabilitation and care, and more robotic-assisted thoracic surgeries. - The report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis. - The release includes a free sample report link: Download a free sample. - The full report is available here: View the full report.

Between the lines: - Rising lung cancer diagnoses are the core demand driver for this market, since surgery equipment is used across diagnosis, treatment and recovery. - The shift toward robotic and minimally invasive procedures suggests competition will likely focus on precision, recovery time and workflow integration rather than basic operating-room hardware. - North America's lead and Asia-Pacific's growth outlook point to a market that is mature in some regions but still expanding in others.

What's next: - The market is likely to keep moving toward devices that combine imaging, monitoring and surgical functions. - Providers and researchers are expected to invest more in ERAS protocols and specialized lung cancer centers. - The next competitive phase will likely center on robotic thoracic surgery and AI-enabled systems.